| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |